Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

10(100.0%)

10Total

N/A(10)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06592001Not ApplicableActive Not Recruiting

Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study

Role: lead

NCT05633394Not ApplicableCompleted

Subcostal Temporary Extravascular Pacing V Study

Role: lead

NCT05610033Not ApplicableCompleted

Pilot evaluatIon Of NovEl tEmpoRary ExtraVascular PACING (PIONEER EV PACING) Study

Role: lead

NCT05791032Not ApplicableCompleted

Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study

Role: lead

NCT05352776Not ApplicableCompleted

Sensing and Defibrillation With a Commercially Available ICD Coupled With a Parasternal Extravascular Lead (SECURE EV) Study

Role: lead

NCT05457673Not ApplicableCompleted

Subcostal Temporary Extravascular Pacing IV (STEP IV) Study

Role: lead

NCT05099289Not ApplicableCompleted

Parasternal Access for ShockS and Pacing With an acUtely Placed Less-invasive Lead for EV-ICD (PASS PULL EV-ICD) Study

Role: lead

NCT04538287Not ApplicableCompleted

AtaCor Subcostal Temporary Extravascular Pacing III Study

Role: lead

NCT04374929Not ApplicableCompleted

Subcostal Temporary Extracardiac Pacing II Study

Role: lead

NCT04096365Not ApplicableCompleted

Subcostal Temporary Extracardiac Pacing Study

Role: lead

All 10 trials loaded